Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Open Medicine Foundation
(section)
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Research Projects == ===End ME/CFS Project=== The End ME/CFS Project is the Open Medicine Foundation's main project, and has been running over a number of years. It aims to: *find a diagnostic tool for ME/CFS *deliver treatments for ME/CFS *ultimately find a cure for ME/CFS<ref name="endmecfs">{{Cite web|url=https://www.omf.ngo/the-end-mecfs-project/ | title = The End ME / CFS Project | last = Open Medicine Foundation | first = | authorlink = Open Medicine Foundation | date = |website=Open Medicine Foundation|language=en-US|archive-url=|archive-date=|url-status=|access-date=2020-05-01}}</ref> The project has run a number of different studies, including the [[ME/CFS Severely Ill, Big Data Study]]. {{See also|End ME/CFS Project}} ===ME/CFS Severely Ill, Big Data Study=== The [[ME/CFS Severely Ill, Big Data Study]] was announced in May, 2015. The most severely ill [[ME/CFS]] patients were being studied to find a [[diagnostic biomarker]]. The project is now complete.<ref name="Davis2019">{{Cite journal | last = Davis | first = R.W. | authorlink = Ronald Davis | last2 = Wilhelmy | first2 = J. | authorlink2=Julie Wilhelmy | last3 = Nemat-Gorgani | first3 = M. | authorlink3 =Mohsen Nemat-Gorgani | last4 = Kashi | first4 = A. | authorlink4 = Alex Kashi | last5 = Esfandyarpour | first5 = R. | authorlink5=Rahim Esfandyarpour | date = Apr 25, 2019 | title = A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)|url=https://www.pnas.org/content/early/2019/04/24/1901274116|journal=Proceedings of the National Academy of Sciences|language=en|volume=116|issue=21|pages=10250-10257|doi=10.1073/pnas.1901274116|issn=0027-8424|pmid=31036648|quote=|via=}}</ref> {{See also|ME/CFS Severely Ill, Big Data Study}} {{See also|A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)}} ===Mestinon trial=== A clinical trial of [[mestinon]] was announced in May 2020. Mestinon is an existing drug which may help with [[post-exertional malaise]] (PEM).<ref name="maymomentum" /> This will be a pilot treatment trial. {{See also|Mestinon}} ===Kynurenine trial=== A pilot treatment trial of [[kynurenine]] was announced in May 2020. Kynurenine is an [[amino acid]] naturally present in the body. This trial is linked to the [[metabolic trap]] hypothesis devised by [[Robert Phair]] after analysis of the data from the [[ME/CFS Severely Ill, Big Data Study]].CFS<ref name="Phair2019">{{Cite journal | last = Phair | first = Robert D. | authorlink = Robert Phair | last2 = Davis | first2 = Ronald W. | authorlink2=Ron Davis | last3 = Kashi | first3 = Alex A. | authorlink3 = Alex Kashi | authorlink4 = | authorlink5 = | authorlink6 = | date = 2019 | title=The IDO Metabolic Trap Hypothesis for the Etiology of ME/CFS|url=https://www.mdpi.com/2075-4418/9/3/82|journal=Diagnostics|language=en|volume=9|issue=3 | pages = 82|doi=10.3390/diagnostics9030082|quote=|via=}}</ref><ref name="maymomentum">{{Cite web|url=https://www.omf.ngo/maymomentum/ | title = #May Momentum 2020 | last = Open Medicine Foundation | first = | authorlink = Open Medicine Foundation | date = |website=Open Medicine Foundation|language=en-US|archive-url=|archive-date=|url-status=|access-date=2020-05-01}}</ref> {{See also|Kynurenine}} {{See also|Metabolic trap}} ===COVID-19 Study=== This project was announced in May 2020, during the [[Severe acute respiratory syndrome coronavirus 2|coronavirus]] pandemic and aims "to track patients with [[COVID-19]] that have been discharged from the ICU, with the expectation that some will develop [[ME/CFS]]." This will involve collecting biological samples from patients, "continuous health tracking" using wearables, and "symptom data collection" over the course of two years.<ref name="maymomentum" /> {{See also|COVID-19 Study}} {{See also|Post-COVID-19 illness}} ===Other projects=== In 2016, [http://www.healthrising.org/blog/2016/05/19/mitochondria-man-gets-money-uk-goes-mega-chronic-fatigue-syndrome-research-moves-forward/ "Mitochondria Man Gets Money UK Goes Mega Chronic Fatigue Syndrome Research Moves Forward"]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs